726 related articles for article (PubMed ID: 29601269)
1. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Jongen-Lavrencic M; Grob T; Hanekamp D; Kavelaars FG; Al Hinai A; Zeilemaker A; Erpelinck-Verschueren CAJ; Gradowska PL; Meijer R; Cloos J; Biemond BJ; Graux C; van Marwijk Kooy M; Manz MG; Pabst T; Passweg JR; Havelange V; Ossenkoppele GJ; Sanders MA; Schuurhuis GJ; Löwenberg B; Valk PJM
N Engl J Med; 2018 Mar; 378(13):1189-1199. PubMed ID: 29601269
[TBL] [Abstract][Full Text] [Related]
2. Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations.
Heuser M; Heida B; Büttner K; Wienecke CP; Teich K; Funke C; Brandes M; Klement P; Liebich A; Wichmann M; Neziri B; Chaturvedi A; Kloos A; Mintzas K; Gaidzik VI; Paschka P; Bullinger L; Fiedler W; Heim A; Puppe W; Krauter J; Döhner K; Döhner H; Ganser A; Stadler M; Hambach L; Gabdoulline R; Thol F
Blood Adv; 2021 May; 5(9):2294-2304. PubMed ID: 33929500
[TBL] [Abstract][Full Text] [Related]
3. Targeted next-generation sequencing of circulating cell-free DNA vs bone marrow in patients with acute myeloid leukemia.
Short NJ; Patel KP; Albitar M; Franquiz M; Luthra R; Kanagal-Shamanna R; Wang F; Assi R; Montalban-Bravo G; Matthews J; Ma W; Loghavi S; Takahashi K; Issa GC; Kornblau SM; Jabbour E; Garcia-Manero G; Kantarjian HM; Estrov Z; Ravandi F
Blood Adv; 2020 Apr; 4(8):1670-1677. PubMed ID: 32324887
[TBL] [Abstract][Full Text] [Related]
4. Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
Archer KJ; Fu H; Mrózek K; Nicolet D; Mims AS; Uy GL; Stock W; Byrd JC; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T; Eisfeld AK
J Hematol Oncol; 2024 May; 17(1):28. PubMed ID: 38702786
[TBL] [Abstract][Full Text] [Related]
5. Genetic mutation signature for relapse prediction in normal karyotype acute myeloid leukemia.
Han L; Wu J; Lyu X; Yu J; Han X; Zhao H; Bian Z; Li W; Fan W; He C; Wang W; Zhang M; Li Y; Liu C; Sun H; Cao H; Sang L; Zhang J; Jiang Z; Peng J
Exp Hematol; 2023 Dec; 128():67-76. PubMed ID: 37739208
[TBL] [Abstract][Full Text] [Related]
6. CD7-positive leukemic blasts with
Bai Y; Sun X; Li M; Niu X; Cao W; Niu J; Xiao X; Chen Y; Sun K
Front Oncol; 2024; 14():1342998. PubMed ID: 38577341
[TBL] [Abstract][Full Text] [Related]
7. Calibration-free NGS quantitation of mutations below 0.01% VAF.
Dai P; Wu LR; Chen SX; Wang MX; Cheng LY; Zhang JX; Hao P; Yao W; Zarka J; Issa GC; Kwong L; Zhang DY
Nat Commun; 2021 Oct; 12(1):6123. PubMed ID: 34675197
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic heterogeneity and the impact on cancer relapse.
Hassan C; Afshinnekoo E; Li S; Wu S; Mason CE
Exp Hematol; 2017 Oct; 54():26-30. PubMed ID: 28705639
[TBL] [Abstract][Full Text] [Related]
9. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression.
Stetson LC; Balasubramanian D; Ribeiro SP; Stefan T; Gupta K; Xu X; Fourati S; Roe A; Jackson Z; Schauner R; Sharma A; Tamilselvan B; Li S; de Lima M; Hwang TH; Balderas R; Saunthararajah Y; Maciejewski J; LaFramboise T; Barnholtz-Sloan JS; Sekaly RP; Wald DN
Leukemia; 2021 Oct; 35(10):2799-2812. PubMed ID: 34244611
[TBL] [Abstract][Full Text] [Related]
10. Considerations regarding maintenance therapy for acute myeloid leukemia in remission.
Schiller GJ; Kustanovich V
Expert Rev Anticancer Ther; 2024; 24(1-2):15-20. PubMed ID: 38230741
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Molecular Residual Disease Assays: Do We Have the Tools to Evaluate Them Properly?
Stetson D; Labrousse P; Russell H; Shera D; Abbosh C; Dougherty B; Barrett JC; Hodgson D; Hadfield J
J Clin Oncol; 2024 May; ():JCO2302301. PubMed ID: 38754043
[No Abstract] [Full Text] [Related]
12. Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Schmitz R; Wright GW; Huang DW; Johnson CA; Phelan JD; Wang JQ; Roulland S; Kasbekar M; Young RM; Shaffer AL; Hodson DJ; Xiao W; Yu X; Yang Y; Zhao H; Xu W; Liu X; Zhou B; Du W; Chan WC; Jaffe ES; Gascoyne RD; Connors JM; Campo E; Lopez-Guillermo A; Rosenwald A; Ott G; Delabie J; Rimsza LM; Tay Kuang Wei K; Zelenetz AD; Leonard JP; Bartlett NL; Tran B; Shetty J; Zhao Y; Soppet DR; Pittaluga S; Wilson WH; Staudt LM
N Engl J Med; 2018 Apr; 378(15):1396-1407. PubMed ID: 29641966
[TBL] [Abstract][Full Text] [Related]
13. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia.
Morita K; Kantarjian HM; Wang F; Yan Y; Bueso-Ramos C; Sasaki K; Issa GC; Wang S; Jorgensen J; Song X; Zhang J; Tippen S; Thornton R; Coyle M; Little L; Gumbs C; Pemmaraju N; Daver N; DiNardo CD; Konopleva M; Andreeff M; Ravandi F; Cortes JE; Kadia T; Jabbour E; Garcia-Manero G; Patel KP; Futreal PA; Takahashi K
J Clin Oncol; 2018 Jun; 36(18):1788-1797. PubMed ID: 29702001
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance.
Bester AC; Lee JD; Chavez A; Lee YR; Nachmani D; Vora S; Victor J; Sauvageau M; Monteleone E; Rinn JL; Provero P; Church GM; Clohessy JG; Pandolfi PP
Cell; 2018 Apr; 173(3):649-664.e20. PubMed ID: 29677511
[TBL] [Abstract][Full Text] [Related]
15. Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC;
N Engl J Med; 2018 May; 378(22):2078-2092. PubMed ID: 29658856
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Characterization of Cancer Driver Genes and Mutations.
Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B; Ng PK; Jeong KJ; Cao S; Wang Z; Gao J; Gao Q; Wang F; Liu EM; Mularoni L; Rubio-Perez C; Nagarajan N; Cortés-Ciriano I; Zhou DC; Liang WW; Hess JM; Yellapantula VD; Tamborero D; Gonzalez-Perez A; Suphavilai C; Ko JY; Khurana E; Park PJ; Van Allen EM; Liang H; ; ; Lawrence MS; Godzik A; Lopez-Bigas N; Stuart J; Wheeler D; Getz G; Chen K; Lazar AJ; Mills GB; Karchin R; Ding L
Cell; 2018 Apr; 173(2):371-385.e18. PubMed ID: 29625053
[TBL] [Abstract][Full Text] [Related]
17. A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with
Levis MJ; Perl AE; Altman JK; Gocke CD; Bahceci E; Hill J; Liu C; Xie Z; Carson AR; McClain V; Stenzel TT; Miller JE
Blood Adv; 2018 Apr; 2(8):825-831. PubMed ID: 29643105
[TBL] [Abstract][Full Text] [Related]
18. The Immune Landscape of Cancer.
Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang TH; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA; Ziv E; Culhane AC; Paull EO; Sivakumar IKA; Gentles AJ; Malhotra R; Farshidfar F; Colaprico A; Parker JS; Mose LE; Vo NS; Liu J; Liu Y; Rader J; Dhankani V; Reynolds SM; Bowlby R; Califano A; Cherniack AD; Anastassiou D; Bedognetti D; Mokrab Y; Newman AM; Rao A; Chen K; Krasnitz A; Hu H; Malta TM; Noushmehr H; Pedamallu CS; Bullman S; Ojesina AI; Lamb A; Zhou W; Shen H; Choueiri TK; Weinstein JN; Guinney J; Saltz J; Holt RA; Rabkin CS; ; Lazar AJ; Serody JS; Demicco EG; Disis ML; Vincent BG; Shmulevich I
Immunity; 2018 Apr; 48(4):812-830.e14. PubMed ID: 29628290
[TBL] [Abstract][Full Text] [Related]
19. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Löwenberg B; Valk PJM
N Engl J Med; 2018 Jun; 378(25):2443. PubMed ID: 29924951
[No Abstract] [Full Text] [Related]
20. A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples.
Chen H; Li C; Peng X; Zhou Z; Weinstein JN; ; Liang H
Cell; 2018 Apr; 173(2):386-399.e12. PubMed ID: 29625054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
